Anti-HER2 antibodies and compositions
US8609095B2 · kind B2 · utility
17Cited by
7References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2011 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | May 22, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel therapeutic antibodies directed against HER2 (ErbB2), as well as recombinant polyclonal anti-HER2 antibody compositions comprising at least two of said recombinant anti-HER2 antibodies, and use of the antibodies and antibody compositions for treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.